Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?
- PMID: 19071972
- PMCID: PMC3577424
- DOI: 10.1037/0893-164X.22.4.472
Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?
Abstract
Nicotine replacement therapies (NRTs) are efficacious smoking-cessation aids. However, only minimal increases in smoking cessation followed NRTs being made available over-the-counter (OTC), which presumably made these treatments more readily available. To better understand why the United States did not experience improvements in smoking cessation following the OTC availability of NRTs, it is useful to review factors that determine NRT's impact on smoking cessation and how these factors played out with the introduction of OTC NRT. The authors contend that for NRTs to have a greater impact on public health, increases are needed in the number of individuals making a quit attempt, the proportion using NRTs in a quit attempt, and the effectiveness of each quit attempt. Even small increases in the impact of OTC NRTs could yield significant benefits in terms of morbidity and mortality. The remainder of this article provides examples of interventions designed to target each of the aforementioned factors individually as well as examples of interventions that link increased cessation attempts, increased NRT reach, and increased NRT efficacy in order to synergistically enhance the impact of OTC NRTs.
2008 APA, all rights reserved
Similar articles
-
Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial.Nicotine Tob Res. 2020 Aug 24;22(9):1468-1475. doi: 10.1093/ntr/ntz138. Nicotine Tob Res. 2020. PMID: 31404466 Clinical Trial.
-
Over-the-counter availability of nicotine replacement therapy and smoking cessation.Nicotine Tob Res. 2005 Aug;7(4):547-55. doi: 10.1080/14622200500185975. Nicotine Tob Res. 2005. PMID: 16085526
-
Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco.Nicotine Tob Res. 2014 Jul;16(7):909-14. doi: 10.1093/ntr/ntu087. Epub 2014 Jun 11. Nicotine Tob Res. 2014. PMID: 24919399 Free PMC article.
-
Economic rewarding of smoking cessation-facilitating drugs--a comparison of over-the-counter and prescribed nicotine replacement therapy.Expert Opin Pharmacother. 2004 Mar;5(3):487-91. doi: 10.1517/14656566.5.3.487. Expert Opin Pharmacother. 2004. PMID: 15013917 Review.
-
Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.Drug Alcohol Rev. 2008 Sep;27(5):529-47. doi: 10.1080/09595230802245527. Drug Alcohol Rev. 2008. PMID: 18696300 Review.
Cited by
-
Pharmacologic agents for smoking cessation: a clinical review.Clin Pharmacol. 2010;2:17-29. doi: 10.2147/CPAA.S8788. Epub 2010 Apr 7. Clin Pharmacol. 2010. PMID: 22291484 Free PMC article.
-
Yoga as a complementary treatment for smoking cessation in women.J Womens Health (Larchmt). 2012 Feb;21(2):240-8. doi: 10.1089/jwh.2011.2963. Epub 2011 Oct 12. J Womens Health (Larchmt). 2012. PMID: 21992583 Free PMC article. Clinical Trial.
-
Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015.Am Health Drug Benefits. 2018 Sep;11(6):275-285. Am Health Drug Benefits. 2018. PMID: 30464795 Free PMC article.
-
Estimates of global research productivity in using nicotine replacement therapy for tobacco cessation: a bibliometric study.Global Health. 2018 Jan 30;14(1):14. doi: 10.1186/s12992-018-0335-z. Global Health. 2018. PMID: 29382348 Free PMC article.
-
Factors Associated with Smoking Cessation and the Receipt of Cessation Services in a Public, Safety-Net Primary Care System.J Gen Intern Med. 2024 Jul;39(9):1657-1665. doi: 10.1007/s11606-024-08664-3. Epub 2024 Feb 8. J Gen Intern Med. 2024. PMID: 38332442 Free PMC article.
References
-
- Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research. 2004;6(Suppl 3):S303–310. - PubMed
-
- Barefoot J, Girodo M. The misattribution of smoking cessation symptoms. Canadian Journal of Behavioral Sciences. 1972;4:358–363.